ESC 365 - Critical appraisal of the CABANA and CASTLE-AF trials.

Open Access

Critical appraisal of the CABANA and CASTLE-AF trials.

Session: Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Topic: Outcomes and Complications

Speaker: Professor I. Van Gelder (Groningen, NL)

Event: ESC Congress 2018

Congress Session

About the speaker

Professor Isabelle C Van Gelder

University Medical Center Groningen, Groningen (Netherlands (The))

40 presentations

2 followers

3 more presentations in this session

Effects of atrial fibrillation ablation in patients with stroke risk factors: the CABANA Trial.

Speaker: Doctor D. Packer (Rochester, US)

Effects of atrial fibrillation ablation in patients with lV dysfunction: the CASTE-AF trial.

Speaker: Professor J. Brachmann (Coburg, DE)

Will the technical improvements in atrial fibrillation ablation further improve the success of atrial fibrillation ablation.

Speaker: Professor G. Hindricks (Leipzig, DE)

Access the full session

Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Speakers: Professor I. Van Gelder, Doctor D. Packer, Professor J. Brachmann, Professor G. Hindricks

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

Related content

Open Access

Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial

27 August 2021

This platform is supported by